Venus Concept Inc. (NASDAQ:VERO) Short Interest Down 42.6% in January

Venus Concept Inc. (NASDAQ:VERO) was the recipient of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 55,500 shares, a decrease of 42.6% from the December 31st total of 96,700 shares. Based on an average daily volume of 946,700 shares, the short-interest ratio is currently 0.1 days. Approximately 1.3% of the company’s stock are short sold.

Venus Concept Stock Down 1.8 %

VERO stock traded down $0.01 during midday trading on Thursday, hitting $0.35. 127,369 shares of the company’s stock were exchanged, compared to its average volume of 277,430. The firm has a 50 day moving average price of $0.35 and a 200-day moving average price of $0.47. Venus Concept has a 12-month low of $0.28 and a 12-month high of $2.22. The stock has a market capitalization of $2.56 million, a price-to-earnings ratio of -0.04 and a beta of 0.47. The company has a current ratio of 1.86, a quick ratio of 1.18 and a debt-to-equity ratio of 2.83.

Venus Concept Company Profile

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.